ATXS
Price
$7.30
Change
+$0.15 (+2.10%)
Updated
Sep 26 closing price
Capitalization
411.97M
46 days until earnings call
CMPX
Price
$3.74
Change
+$0.25 (+7.16%)
Updated
Sep 26 closing price
Capitalization
641.68M
40 days until earnings call
Interact to see
Advertisement

ATXS vs CMPX

Header iconATXS vs CMPX Comparison
Open Charts ATXS vs CMPXBanner chart's image
Astria Therapeutics
Price$7.30
Change+$0.15 (+2.10%)
Volume$291.43K
Capitalization411.97M
Compass Therapeutics
Price$3.74
Change+$0.25 (+7.16%)
Volume$1.52M
Capitalization641.68M
ATXS vs CMPX Comparison Chart in %
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. CMPX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Buy and CMPX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ATXS: $7.30 vs. CMPX: $3.74)
Brand notoriety: ATXS and CMPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 90% vs. CMPX: 117%
Market capitalization -- ATXS: $411.97M vs. CMPX: $641.68M
ATXS [@Biotechnology] is valued at $411.97M. CMPX’s [@Biotechnology] market capitalization is $641.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileCMPX’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • CMPX’s FA Score: 0 green, 5 red.
According to our system of comparison, ATXS is a better buy in the long-term than CMPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 4 TA indicator(s) are bullish while CMPX’s TA Score has 5 bullish TA indicator(s).

  • ATXS’s TA Score: 4 bullish, 6 bearish.
  • CMPX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CMPX is a better buy in the short-term than ATXS.

Price Growth

ATXS (@Biotechnology) experienced а +3.55% price change this week, while CMPX (@Biotechnology) price change was +10.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ATXS is expected to report earnings on Nov 12, 2025.

CMPX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMPX($642M) has a higher market cap than ATXS($412M). CMPX YTD gains are higher at: 157.931 vs. ATXS (-18.345). CMPX has higher annual earnings (EBITDA): -66.29M vs. ATXS (-131.42M). ATXS has more cash in the bank: 259M vs. CMPX (101M). ATXS has less debt than CMPX: ATXS (4.77M) vs CMPX (9.9M). ATXS (0) and CMPX (0) have equivalent revenues.
ATXSCMPXATXS / CMPX
Capitalization412M642M64%
EBITDA-131.42M-66.29M198%
Gain YTD-18.345157.931-12%
P/E RatioN/AN/A-
Revenue00-
Total Cash259M101M256%
Total Debt4.77M9.9M48%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSCMPX
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 13 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PQCCX10.030.11
+1.11%
PGIM Quant Solutions Mid-Cap Index R6
MASPX31.220.30
+0.97%
BlackRock Advantage SMID Cap Instl
EPDIX13.040.12
+0.93%
EuroPac International Dividend Income I
PNOPX129.630.48
+0.37%
Putnam Sustainable Leaders A
GTSVX39.46N/A
N/A
Invesco Small Cap Growth R5

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with CRNX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+2.10%
CRNX - ATXS
53%
Loosely correlated
+27.92%
DNLI - ATXS
51%
Loosely correlated
+3.87%
XENE - ATXS
51%
Loosely correlated
+4.00%
VRDN - ATXS
51%
Loosely correlated
+5.82%
OCUL - ATXS
50%
Loosely correlated
+2.37%
More

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with VIR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
+7.16%
VIR - CMPX
38%
Loosely correlated
+5.98%
PLRX - CMPX
33%
Loosely correlated
+5.56%
CPRX - CMPX
33%
Loosely correlated
+2.04%
ARVN - CMPX
33%
Poorly correlated
+6.71%
ATXS - CMPX
33%
Poorly correlated
+2.10%
More